Booth No.4T-39
CategoryIngredients
PavilionChina Pavilion
Sichuan Qingmu Pharmaceutical Co., Ltd.
Booth No.：4T-39
Category：Ingredients
Pavilion：China Pavilion
Company Information
Email：
sales@eastonpharma.cn
TEL： +86-28-8782-7187
Address： 612100
No.55, South Shunjiang Avenue, East Economic Development Zone, Dongpo District , Meishan City, Sichuan Province, 620036 CHINA URL： http://www.qingmupharm.com/
No.55, South Shunjiang Avenue, East Economic Development Zone, Dongpo District , Meishan City, Sichuan Province, 620036 CHINA URL： http://www.qingmupharm.com/
Sichuan Qingmu Pharmaceutical Co., Ltd., founded in May 2011, is a wholly-owned subsidiary of Chengdu Easton Biopharmaceuticals Co.,Ltd. (Sock code: 688513).
Qingmu is an innovation driven pharmaceutical company with primary strategic focus on the regulated market, the company speciallize in R&D and manufacturing of generic APIs and advanced intermediates, and also provides CDMO/CMO service for small molecule chemical drugs.
Qingmu is an innovation driven pharmaceutical company with primary strategic focus on the regulated market, the company speciallize in R&D and manufacturing of generic APIs and advanced intermediates, and also provides CDMO/CMO service for small molecule chemical drugs.
Company information
| Address | 612100 No.55, South Shunjiang Avenue, East Economic Development Zone, Dongpo District , Meishan City, Sichuan Province, 620036 CHINA |
|---|---|
| TEL | +86-28-8782-7187 |
| URL | http://www.qingmupharm.com/ |
| sales@eastonpharma.cn |
| Product introduction |
Abemaciclib Aprepitant Bisoprolol Fumarate Dabigatran Etexilate Mesylate Rotigotine Sugammadex Sodium Silodosin Brexpiprazole Mirogabalin Lubribinectedin Omadacycline Tosylate Lenvatinib Mesilate Nilotinib Hydrochloride Relugolix Niraparib Oclacitiib Maleate Afoxolaner Firocoxib Fluralaner Maropitant Citrate |
|---|
Product introduction
AbemaciclibAprepitantBisoprolol FumarateDabigatran Etexilate MesylateRotigotineSugammadex SodiumSilodosinBrexpiprazoleMirogabalinLubribinectedinOmadacycline TosylateLenvatinib MesilateNilotinib HydrochlorideRelugolixNiraparibOclacitiib MaleateAfoxolanerFirocoxibFluralanerMaropitant Citrate